Astrazeneca Plc (GB:0A4J)

AstraZeneca (0A4J) Stock Price & Analysis


0A4J Stock Chart & Stats

Day’s Range$0 - $0
52-Week Range$52.05 - $71.05
Previous Close$67.74
Average Volume (3M)139.39K
Market Cap
Enterprise Value$214.72B
Total Cash (Recent Filing)£0.00
Total Debt (Recent Filing)£0.00
Price to Earnings (P/E)63.8
Apr 28, 2023
1.42 (2.09%)
Share Statistics
EPS (TTM)1.06
Shares Outstanding3,099,666,974
10 Day Avg. Volume150,212
30 Day Avg. Volume139,393
Standard Deviation0.05
Financial Highlights & Ratios
Price to Book (P/B)-9.15
Price to Sales (P/S)0.05
Price to Cash Flow (P/CF)21.20
P/FCF Ratio176.70
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Price Target Upside101.24% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering3




What was Astrazeneca Plc’s price range in the past 12 months?
Astrazeneca Plc lowest stock price was $52.05 and its highest was $71.05 in the past 12 months.
    What is Astrazeneca Plc’s market cap?
    Currently, no data Available
    When is Astrazeneca Plc’s upcoming earnings report date?
    Astrazeneca Plc’s upcoming earnings report date is Apr 28, 2023 which is in 31 days.
      How were Astrazeneca Plc’s earnings last quarter?
      Astrazeneca Plc released its earnings results on Feb 09, 2023. The company reported $0.69 earnings per share for the quarter, beating the consensus estimate of $0.672 by $0.018.
        Is Astrazeneca Plc overvalued?
        According to Wall Street analysts Astrazeneca Plc’s price is currently Undervalued. Get more investment ideas with TipRanks Premium
          Does Astrazeneca Plc pay dividends?
          Astrazeneca Plc pays a Semiannually dividend of $0.96 which represents an annual dividend yield of 2.09%. See more information on Astrazeneca Plc dividends here
            What is Astrazeneca Plc’s EPS estimate?
            Astrazeneca Plc’s EPS estimate is $0.87.
              How many shares outstanding does Astrazeneca Plc have?
              Astrazeneca Plc has 1,549,833,500 shares outstanding.
                What happened to Astrazeneca Plc’s price movement after its last earnings report?
                Astrazeneca Plc reported an EPS of $0.69 in its last earnings report, beating expectations of $0.672. Following the earnings report the stock price went up 4.87%.
                  Which hedge fund is a major shareholder of Astrazeneca Plc?
                  Among the largest hedge funds holding Astrazeneca Plc’s share is PRIMECAP Management Co. It holds Astrazeneca Plc’s shares valued at 3B.


                    AstraZeneca Stock Smart Score

                    The AstraZeneca Holdings stock analysis is based on the TipRanks Smart Score which is derived from 6 unique data sets including Analyst recommendations, Media Sentiment and multiple Technical stock factors. The Smart Score is a quantitative, data-driven rating system and does not include human intervention.
                    Learn more about TipRanks Smart Score

                    Company Description

                    Astrazeneca Plc

                    Founded in 1992, UK-based AstraZeneca Plc is a leading global pharmaceutical company, which is engaged in delivering life-changing medicines. The company produces and commercializes medicines for cancer, gastrointestinal, cardiovascular, neuroscience, oncology, respiratory and inflammation and other infectious diseases.


                    Forecast EPS vs Actual EPS

                    Similar Stocks
                    Price & Change
                    Hikma Pharmaceuticals
                    Dechra Pharmaceuticals

                    Popular Stocks

                    What's Included in PREMIUM?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis